Selected drugs that received regulatory approval in 2008.
|Abbott (NYSE:ABT)||Simcor extended-release niacin / immediate-release simvastatin||Manage cholesterol in patients with complex lipid disease when treatment with either therapy alone is not adequate||U.S.|
|Adolor (NASDAQ:ADLR)/ GlaxoSmithKline (LSE:GSK; NYSE:GSK)||Entereg alvimopan||Postoperative ileus (POI)||U.S.|
|Alcon (NYSE:ACL)||Patanase olopatadine hydrochloride nasal spray||Seasonal allergic rhinitis||U.S.|
|Allergan (NYSE:AGN)||Trivaris triamcinolone||Intravitreal, intramuscular or intra-articular injection to treat sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids||U.S.|
|Allergan (NYSE:AGN)||Latisse bimatoprost ophthalmic solution 0.03%||Hypotrichosis|